NantHealth, Inc. Quarterly Return On Equity in % from Q3 2020 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NantHealth, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2020 to Q3 2023.
  • NantHealth, Inc. Return On Equity for the quarter ending September 30, 2023 was 29.2 %, a 9.81% decline year-over-year.
  • NantHealth, Inc. annual Return On Equity for 2022 was 34.3 %, a 15.2% decline from 2021.
  • NantHealth, Inc. annual Return On Equity for 2021 was 40.4 %, a 42.7% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 29.2 -3.17 -9.81% Jul 1, 2023 Sep 30, 2023
Q2 2023 30.1 -3.13 -9.41% Apr 1, 2023 Jun 30, 2023
Q1 2023 30.1 -7.74 -20.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 34.3 -6.16 -15.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 32.3 -14.6 -31.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 33.3 -19.2 -36.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 37.9 -53 -58.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 40.4 -30.1 -42.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 46.9 -25.4 -35.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 52.4 Apr 1, 2021 Jun 30, 2021
Q1 2021 90.8 Jan 1, 2021 Mar 31, 2021
Q4 2020 70.5 Oct 1, 2020 Dec 31, 2020
Q3 2020 72.3 Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.